Specification of health data transfer from devices to DiGA (§ 374a SGB V)
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These are custom operations that can be supported by and/or invoked by systems conforming to this implementation guide.
| Search Operation for summary data measurement |
The Use cases supported by this operation include:
Input Parameters:
Output Parameter:
Error handling (OperationOutcome):
|
These define constraints on FHIR resources for systems conforming to this implementation guide.
| Bundle – HDDT CGM Summary Report |
This profile defines the exchange of aggregated measurement data for the Mandatory Interoperable Value (MIV) "Continuous Glucose Measurement". By this it provides a patient’s glucose profile for a defined period. The MIV "Continuous Glucose Measurement" is e.g. implemented by real-time Continuous Glocose Monitoring devices (rtCGM) and Automated Insulin Delivery systems (AID) that control an insulin pump from rtCGM data. Future non-invasive measuring methods will expectedly be linked with this MIV and therefore use this profile for sharing aggregated glucose profile data with DiGA, too. This profile constrains the FHIR Bundle resource for use as the result container of the The Bundle is of type collection and MUST contain only resources of the following types:
The purpose of this Bundle profile is to provide a consistent structure for server responses when clients query for CGM data with aggregation logic.
Constraints applied:
|
| Device – Personal Health Device |
This profile defines a Personal Health Device within the context of § 374a SGB V. A Personal Health Device acc. to this profile is any medical aid or implant that
Personal Health Devices that fulfill the criteria of this regulation MUST be able to pass on data to authorized Digital Health Applications (DiGA acc. § 374a SGB V) using the protocols and interfaces as defined in the HDDT specification. This profile helps a device data consuming DiGA to
Obligations and Conventions: The Personal Health Device’s backend regularely synchronizes with the device hardware through a gateway (Personal Health Gateway).
The maximum delay that the concrete end-to-end synchronization from the Personal Health Device to the FHIR resource server imposes is provided by the BfArM HIIS-VZ (Device Registry)
through the static attribute Constraints applied:
|
| DeviceMetric – Sensor Type and Calibration Status |
The HddtSensorTypeAndCalibrationStatus profile captures the calibration status of a sensor which is part of a Personal Health Device. Personal Health Devices need to be calibrated in order to provide safe measurements. Some devices are already calibrated by the manufacturer while others calibrate themselves after activation and others need to be calibrated by the patient. If a Personal Health Device transmits data from a non calibrated sensor to the resource server at all depends on the concrete product. For a DiGA as a device data consumer to process device data in a safe manner, it must be transparent if the data it received was measured by a calibrated sensor or not. For devices where the sensor that measured a value requires automated or manual calibration, the Observation capturing this value
MUST refer to a HddtSensorTypeAndCalibrationStatus resource through its The HddtSensorTypeAndCalibrationStatus of a measurement MUST always refer to a HddTPersonalHealthDevice Device resource that represents the Personal Health Device that contains the sensor. This is a many-to-one relationship which allows for a Personal Health Device to contain multiple sensors for different measured values. E.g. by this a pulse oximeter as a HDDT Personal Health Device can provide pulse and SPO2 as two different interoperable values with each of this values being linked with a dedicated HddtSensorTypeAndCalibrationStatus resource. Obligations and Conventions: DiGA as device data consumers SHOULD NOT rely on the Constraints applied:
|
| Observation – Blood Glucose Measurement |
Profile for capturing blood glucose measurements as FHIR Observation resources. This profile defines the exchange of a single measurement data for the Mandatory Interoperable Value (MIV) "Blood Glucose Measurement" which is technically defined by the ValueSet hddt-miv-blood-glucose-measurement. This MIV is e.g. implemented by blood glucose meter (glucometer) that can connect to a Personal Health Gateway (e.g. a mobile app for keeping diabetes diary) through wireless or wired communication. Obligations and Conventions: Each Blood Glucose Measurement MUST either hold a reference to a Sensor Type And Calibration Status DeviceMetric resource or to a Personal Health Device Device resource (eXclusive OR). A reference to Sensor Type And Calibration Status MUST be provided from the Observation resource if the sensor for measuring blood glucose needs to be calibrated (either automatically or by the user) or if the sensor may change its calibration status over time. Constraints applied:
|
| Observation – Continuous Glucose Measurement |
Profile for capturing continuous glucose measurements from real-time monitoring devices (esp. rtCGM). This profile defines the exchange of raw measurement data for the Mandatory Interoperable Value (MIV) "Continuous Glucose Measurement" which is technically defined by the ValueSet hddt-miv-continuous-glucose-measurement. This MIV is e.g. implemented by real-time Continuous Glocose Monitoring devices (rtCGM) and Automated Insulin Delivery systems (AID) that control an insulin pump from rtCGM data. Future non-invasive measuring methods will expectedly be linked with this MIV and therefore use this profile for sharing data with DiGA, too. Obligations and Conventions: Devices for continuously measuring glucose values may produce data with a sample rate of more than 1000 values per day (e.g. current
rtCGM provide measures for glucose in interstitial fluid with up to one value per minute). For sharing such data efficently, this profile
makes use of the FHIR sampledData data type. Sampled data is portioned into
chunks of a fixed size (for an exception see below), with the chunk size being set by the resource server (e.g. such that 24 h of measurements fit into a single chunk). If a DiGA
requests data for a period where the end time is earlier that the expected end time of the current chunk, the resource server only fills up the chunk
up to the requested end time and sets the Each Continuous Glucose Measurement MUST either hold a reference to a Sensor Type And Calibration Status DeviceMetric resource or to a
Personal Health Device Device resource (eXclusive OR). A reference to Sensor Type And Calibration Status MUST be provided
from the Observation resource if the sensor for continuous measuring needs to be calibrated (either automatically or by the user)
or if the sensor may change its calibration status over time. A change in Constraints applied:
|
These define sets of codes used by systems conforming to this implementation guide.
| Device Type of personal health devices |
This ValueSet includes codes used to identify Personal Health Devices and Device Data Recorders. This ValueSet’s definition is a subset of the definition of the FHIR R5 ValueSet Device Type, adapted for use with the FHIR R4 based HDDT profiles. This ValueSet includes concepts from ISO/IEEE 11073-10101:2020, SNOMED CT and HL7 International. Codes from the ISO/IEEE 11073-10101 Health informatics — Point-of-care medical device communication — Nomenclature standard are included under the terms of HL7 International’s licensing agreement with the IEEE. Users of this specification may reference individual codes as part of HL7 FHIR-based implementations. However, the full ISO/IEEE 11073 code system and its contents remain copyrighted by ISO and IEEE. |
| ValueSet - Blood Glucose Measurement from LOINC |
This ValueSet defines the Mandatory Interoperable Value (MIV) "Blood Glucose Measurement". The definition is made up from
The MIV Blood Glucose Measurement covers values from "bloody measurements" e.g. using capillary blood from the finger tip. Measurements are performed based on a care plan (e.g. measuring blood sugar before each meal) or ad hoc (e.g. a patient feeling dim what may be an indicator for a hypoglycamia). Values are very acurate and therefore suited for therapeutical decision making. The ValueSet for the MIV Blood Glucose Measurement contains LOINC codes for blood glucose measurements using blood or plasma as reference methods with the values provided as mass/volume and moles/volume. In addition more granular LOINC codes for "Glucose in Capillary blood by Glucometer" provided as mass/volume and moles/volume are included with the value set because these codes are already in use by several manufacturers of glucometers. |
| ValueSet – Continuous Glucose Measurement from LOINC |
This ValueSet defines the Mandatory Interoperable Value (MIV) "Continuous Glucose Measurement". The definition is made up from
The MIV Continuous Glucose Measurement covers values from continuous monitoring of the glucose level, e.g. by rtCGM in interstitial fluid (ISF). Measurements are performed through sensors with a sample rate of up to one value per minute. By this Continuous Glucose Measurement can e.g. be used to assess dependencies between a patient’s individual habits and behavious and his glucose level. Due to the high density of values over a long period of time, many key metrics can be calculated from Continuous Glucose Measurement which help the patient and his doctor to easily capture the status of the patient’s health and therapy. The ValueSet for the MIV Continuous Glucose Measurement includes codes relevant to continuous glucose monitoring (CGM) in interstitial fluid (ISF), considering mass/volume and moles/volume as commonly used units. In the future codes defining non-invasive glucose measuring methods may be added to this value set. |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| HDDT Blood Glucose Measurement 1 (from Example Object Diagram) |
Example of a blood glucose measurement taken with a glucometer. |
| HDDT Blood Glucose Measurement 2 (from Example Object Diagram) |
Example of a blood glucose measurement taken with a glucometer. |
| HDDT Blood Glucose Obervation Example (general) |
Example of a blood glucose measurement taken with a glucometer. |
| HDDT Glucometer Device Example |
Example of a glucometer as a personal health device: The device GlukkCheck plus mg/dl from Glukko Inc. performs “bloody” measurements from capillary blood. As glucometers do not expire (that is just the case for the test stripes), the expiration date is not set. The vendor-defined model number of this typeof devices is CGPA987654 and the serial number of the patient’s individual device is SN123456. Both identifiers are printed on the back of the device and allow the patient to validate the authenticity of this Personal Health Device resource. |
| HDDT Glucometer DeviceDefinition Example |
Example for a medical device definition (Glucometer) from the HIIS-VZ. |
| HDDT Glucometer DeviceMetric Example |
Example of a DeviceMetric for blood glucose measurements from a glucometer: The device measures the glucose concentration from capillary blood by using test strips. The patient’s preferred unit is mg/dl which is used by the device for displaying measured values. The glucometer needs to be calibrated by the patient using control strips. The last calibration was performed in Septemer 2025 and the glucometer is still calibrated. |
| HDDT rtCGM Data Unavailable Observation Example |
Example of a CGM time series with status preliminary and dataAbsentReason |
| HDDT rtCGM Device Example |
Example of a real-time Continuous Glucose Monitoring device (rtCGM) as a personal health device: The device GlukkoCGM 18 from Glukko Inc. performs continuous glucose measurements from interstitial fluid. The sensor stops transmitting data on September 10, 2025, and must be replaced by the patient at that date. The vendor-defined model number of this typeof devices is GCGMA98765 and the serial number of the patient’s individual device is CGM1234567890. Both identifiers are printed on the package of the device and allow the patient to validate the authenticity of this Personal Health Device resource. |
| HDDT rtCGM DeviceDefinition Example |
This example represents a Continuous Glucose Monitoring (CGM) device definition from the HIIS-VZ. |
| HDDT rtCGM DeviceMetric Example |
Example configuration for measurements from a real-time Continuous Glucose Monitoring (rtCGM): The device measures the glucose concentration from interstitial fluid with a frequency of one measurement every minute. The the unit set by the patient for displaying measured values is mg/dl. The device is calibrated by the manufacturer and does not require user calibration. |
| HDDT rtCGM Full Chunk Observation Example |
Example of a CGM time series with 1-minute intervals over 1 hour (60 samples). |
| HDDT rtCGM Full Chunk Observation Example |
Example of a CGM time series with 5-minute intervals over 1 hour (12 samples). |
| HDDT rtCGM Incomplete Chunk Observation Example |
Example of a CGM time series with 1-minute intervals over 20 minutes (20 samples), but incomplete. |
| HL7 CGM Summary OperationOutcome Example: Bad syntax error |
Returned when the request is malformed. |
| HL7 CGM Summary OperationOutcome Example: Invalid parameter error |
Returned when a parameter value is invalid. |
| HL7 CGM Summary OperationOutcome Example: No results information |
Returned when no CGM observations are found. |
| HL7 CGM Summary OperationOutcome Example: Unknown parameter error |
Returned when an unsupported input parameter is provided. |
| HL7 CGM Summary Patient Example: no content |
This example represents a patient without content. |
| HL7 CGM Summary: CGM Summary Example |
This example is an instance of the CGM Summary profile. It provides a consolidated summary of a patient’s CGM data over one month, linking to more detailed observations for specific metrics. |
| HL7 CGM Summary: Coefficient of Variation Example |
This example is an instance of the Coefficient of Variation (CV) profile. It represents a summary observation of the glucose variability for a patient over the period from May 1, 2024, to May 31, 2024, with a final recorded coefficient of variation value of 34%. |
| HL7 CGM Summary: Days of Wear Example |
This example is an instance of the Days of Wear profile. It represents a summary observation of the number of days a Continuous Glucose Monitoring (CGM) device was worn by the patient over the period from May 1, 2024, to May 31, 2024, with a final recorded value of 28 days. |
| HL7 CGM Summary: Example Bundle |
Bundle containing CGM summary observations for a patient together with associated Device and DeviceMetric resources. |
| HL7 CGM Summary: GMI Example |
This example is an instance of the Glucose Management Indicator (GMI) profile. It represents a summary observation of the estimated A1C-like value (GMI) for a patient over the period from May 1, 2024, to May 31, 2024, with a final recorded value of 6.8%. |
| HL7 CGM Summary: Mean Glucose (Mass) Example |
This example is an instance of the Mean Glucose (Mass) profile. It represents a summary observation of the mean glucose level for a patient over the period from May 1, 2024, to May 31, 2024, with a final recorded value of 145 mg/dL (mass per volume). |
| HL7 CGM Summary: Mean Glucose (Molar) Example |
This example is an instance of the Mean Glucose (Molar) profile. It represents a summary observation of the mean glucose level for a patient over the period from May 1, 2024, to May 31, 2024, with a final recorded value of 8.1 mmol/L (moles per volume). |
| HL7 CGM Summary: Sensor Active Percentage Example |
This example is an instance of the Sensor Active Percentage profile. It represents a summary observation of the percentage of time a Continuous Glucose Monitoring (CGM) sensor was active for the patient over the period from May 1, 2024, to May 31, 2024, with a final recorded value of 95%. |
| HL7 CGM Summary: Times in Ranges Example |
This example is an instance of the CGM Summary Times in Ranges profile. It represents a summary observation of the time a patient spent in different glucose ranges over the period from May 1, 2024, to May 31, 2024. The recorded values are 3% in the very low range, 8% in the low range, 65% in the target range, 20% in the high range, and 4% in the very high range. |